-+ 0.00%
-+ 0.00%
-+ 0.00%

Sensei Biotherapeutics changes name to Faeth Therapeutics, adopts ticker FTH

PUBT·06/15/2026 12:10:16
Listen to the news
Sensei Biotherapeutics changes name to Faeth Therapeutics, adopts ticker FTH
  • Sensei Biotherapeutics rebranded as Faeth Therapeutics, pivoting to PIKTOR, an oral multi-node inhibitor of the PI3K/AKT/mTOR pathway.
  • Common stock expected to trade on Nasdaq under ticker FTH on June 16, 2026.
  • Company cited $200 million in gross proceeds from a private placement tied to its February 2026 Faeth acquisition.
  • PIKTOR Phase 2 topline data in advanced endometrial cancer targeted for the second half of 2026; breast cancer interim data expected in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606150810BIZWIRE_USPR_____20260615_BW392682) on June 15, 2026, and is solely responsible for the information contained therein.